NOVARTIS CAP P Performance
| 66989HAH1 | 92.77 3.25 3.63% |
The bond secures a Beta (Market Risk) of 0.34, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NOVARTIS's returns are expected to increase less than the market. However, during the bear market, the loss of holding NOVARTIS is expected to be smaller as well.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NOVARTIS CAP P are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, NOVARTIS is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Yield To Maturity | 5.517 |
NOVARTIS |
NOVARTIS Relative Risk vs. Return Landscape
If you would invest 9,001 in NOVARTIS CAP P on November 9, 2024 and sell it today you would earn a total of 276.00 from holding NOVARTIS CAP P or generate 3.07% return on investment over 90 days. NOVARTIS CAP P is generating 0.0593% of daily returns and assumes 0.9434% volatility on return distribution over the 90 days horizon. Simply put, 8% of bonds are less volatile than NOVARTIS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
NOVARTIS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NOVARTIS's investment risk. Standard deviation is the most common way to measure market volatility of bonds, such as NOVARTIS CAP P, and traders can use it to determine the average amount a NOVARTIS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0628
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 66989HAH1 | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.94 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average NOVARTIS is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NOVARTIS by adding it to a well-diversified portfolio.
About NOVARTIS Performance
By analyzing NOVARTIS's fundamental ratios, stakeholders can gain valuable insights into NOVARTIS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NOVARTIS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NOVARTIS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.